A SARC global collaborative phase II trial of R1507, a recombinant human monoclonal antibody to the insulin-like growth factor-1 receptor (IGF1R) in patients with recurrent or refractory sarcomas
Year: 2009
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: S. Patel, A. Pappo, J. Crowley, D. Reinke, J. Eid, S. Ritland, S. Chawla, A. Staddon, R. Maki, G. Vassal, L. Helman
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2339772802